What is IPO Grey Market Premium (GMP)?

IPO Grey Market Premium (GMP) is an unofficial, over-the-counter premium over the issue price that dealers and investors pay prior to official listing on NSE/BSE.

How is estimated IPO listing price determined?

Estimated Listing Price = Cut-off / Issue Price + Current Grey Market Premium (GMP). For example, an issue price of ₹100 with ₹40 GMP yields an estimated listing price of ₹140 (+40%).

What is Kostak rate in an IPO?

Kostak rate is the fixed profit earned by selling an IPO application before allotment, irrespective of whether the application is allotted shares or not.

What is Subject to Sauda in IPO trading?

Subject to Sauda is an informal contract where payment is made only if the seller receives share allotment in the IPO.

Is IPO Grey Market Premium (GMP) regulated by SEBI?

No. Grey Market transactions are non-exchange over-the-counter commitments and are not officially regulated or endorsed by SEBI. Investors should treat GMP as an informal sentiment indicator.

What is the current subscription status of Cell Point (India) Limited IPO?

Cell Point (India) Limited IPO has received a total subscription of 6.04 times overall.

IPO GreyPremiumLIVE

Grey Market Intelligence

Cell Point (India) Limited

ListedSME

Retail & Consumer Electronics · NSE

Incorporated in 2001, Cell Point (India) Limited is a multi-brand retail company engaged in the sale of smartphones, tablets, mobile accessories, and other related products from leading manufacturers like Apple, Samsung, Oppo, Vivo, Xiaomi, Realme, Nokia, Redmi, and OnePlus. The company also retails consumer electronic goods, including Smart TVs from brands such as Xiaomi, Realme, and OnePlus. With a strong retail presence across Andhra Pradesh, Cell Point operates over 75 stores — 2 owned and 73 leased — catering to diverse customer needs in the electronics and mobile retail segment.

Price Band

₹100

Issue Size

₹50.34 Cr

Lot Size

1200 shares

GMP

—

Est. Listing

₹100

at current GMP

Subscribed

6.04x

overall

Open

15 Jun 2023

20 Jun 2023

Allotment

23 Jun 2023

Refund

24 Jun 2023

Demat Credit

25 Jun 2023

Listing

28 Jun 2023

Last updated 12 days ago

Overview Live GMP Subscription Status Allotment Status Filing Documents

Overall Subscription

6.04x

Total Demand

QIB Multiplier

0.00x

Institutions & Funds

NII / HNI

4.17x

High Net-Worth

Retail (RII)

7.92x

Individual Bidders

Category-Wise Subscription Breakup

Live bidding breakdown by institutional, non-institutional, and retail investors

Total 6.04x

Category	Shares Offered	Shares Applied / Bid	Times Subscribed
NIB	2,391,000	9,966,000	4.17x
RETAIL	2,391,000	18,937,200	7.92x
Total	4,782,000	28,903,200	6.04x

Application-Wise Breakup

Total unique applications received across retail and HNI tranches

Apps 7.79x

Category	Applications Reserved	Applications Received	Times Subscribed
Retail (RII)	1,468	11,627	7.92x
HNIs (10L +)	9	38	4.17x
HNIs (2-10L)	45	188	4.17x
Total Applications	1,522	11,853	7.79x

Day-Wise Subscription Progress

Track continuous institutional and retail bidding order books for all active issues on the ipo live subscription feed.

About Cell Point (India) Limited Public Issue & Market Profile

Cell Point (India) Limited is bringing an initial public offering (IPO) in the Retail & Consumer Electronics sector with an aggregate issue size of ₹50.34 Crores. The shares are offered at a price band of ₹100 to ₹100 per equity share on NSE. Currently, market analysts recommend evaluating the company's financial valuation, price-to-earnings (P/E) multiple, and peer comparison prior to submitting bids.

Bidding & Quota Instructions:

The public offer consists of a fresh issue and offer-for-sale structured under SEBI regulations. Bidding is open to Qualified Institutional Buyers (QIB), Non-Institutional Bidders (NII/HNI), and Retail Individual Investors (RII). Applications can be submitted online using ASBA or UPI mandate through certified stock brokers and net banking portals.

Allotment Reconciliation Schedule:

Following the close of bidding on 2023-06-20, the basis of allotment is scheduled to be finalized on 2023-06-23. Investors can verify their application status online by submitting their PAN card number, Application Number, or DP Client ID on the registrar's official portal (Bigshare Services Private Limited) or the BSE allotment checking window.

Frequently Asked Questions

What is Cell Point (India) Limited IPO GMP today?

Currently, Cell Point (India) Limited IPO Grey Market Premium (GMP) is not actively quoted or is quoted flat at ₹0. The shares are expected to list close to the issue price band of ₹100 to ₹100 per equity share.

What is the expected profit per lot for Cell Point (India) Limited IPO?

The retail lot size is 1200 shares requiring a minimum application amount of ₹1,20,000. Expected listing price is ₹100 per equity share.

What is the issue size and price band for Cell Point (India) Limited IPO?

The Cell Point (India) Limited IPO aggregate issue size is ₹50.34 Crores with an equity price band set at ₹100 to ₹100 per equity share. The retail lot size is 1200 shares requiring a minimum capital outlay of approx. ₹1,20,000.

How can I check Cell Point (India) Limited IPO live subscription demand?

Live subscription figures are compiled real-time from the NSE and BSE bidding engines. Currently, overall subscription is 6.04x (Retail: 7.92x, QIB: 0.00x, NII: 4.17x). You can track live multiples directly on our dedicated subscription page.

Where and when will Cell Point (India) Limited IPO allotment status be published?

The basis of allotment will be published on the official registrar portal (Bigshare Services Private Limited) and the BSE status verification website on or around 2023-06-23. Investors can verify status using PAN card or application number.

When is the listing date for Cell Point (India) Limited IPO?

Cell Point (India) Limited shares are scheduled to list on NSE on 2023-06-28.